Australia's LTR Pharma surges as its drug begins US prescription fulfillment
06/10/2026 03:46
BUZZ-Australia's LTR Pharma surges as its drug begins US prescription fulfillment ** Shares of Australia's LTR Pharma LTP.AX rise as much as 13.3% at A$0.560, hitting their highest level since August 11
** Biopahrmaceutical co says first patient prescriptions have now been filled for ROXUS, co's nasal spray treatment for erectile dysfunction, in the US
** Adds patients can now obtain the drug through Mavrox, an online men's health platform
** Says will focus on supporting US partners as prescribing and prescription activity builds
** Stock down 28.3% YTD
(Reporting by Shravya Marakini in Bengaluru)
Recent news on Ltr Pharma
See all newsAustralia's LTR Pharma surges as its drug begins US prescription fulfillment
Brief: LTR Pharma Executes Exclusive Pilot Agreement With Marius Pharmaceuticals, Inc For Kyzatrex
Brief: LTR Pharma Executes U.S. Commercial Agreement With Strive
Australia's LTR Pharma rises on commercial tie-up with US telehealth firm
Australia's LT Pharma gains after nod to test nasal spray